Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Small-scale Extracorporeal Photopheresis for the Treatment of Acute Graft-versus-Host Disease
DRKS00000299Phase 2Withdrawn
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methoxsalen in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Universitätsklinikum Freiburg. Planned start Jan 2010; status: withdrawn.
02
Drugs
methoxsalen
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on DRKS00000299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000299.